Search

Jeffery S Loutit

from Los Altos, CA
Age ~67

Jeffery Loutit Phones & Addresses

  • 1190 Brucito Ave, Los Altos, CA 94024 (650) 941-2656 (650) 964-9501
  • Los Altos Hills, CA
  • Sunriver, OR
  • Palo Alto, CA
  • Cleveland, OH
  • Santa Clara, CA
  • 1190 Brucito Ave, Los Altos, CA 94024 (650) 888-5007

Work

Position: Service Occupations

Education

School / High School: University of Otago /Dunedin Medical School

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Infectious Disease, 2000

Specialities

Infectious Disease Medicine

Professional Records

Medicine Doctors

Jeffery Loutit Photo 1

Dr. Jeffery S Loutit, Los Altos CA - MD (Doctor of Medicine)

View page
Specialties:
Infectious Disease Medicine
Address:
1190 Brucito Ave, Los Altos, CA 94024
Certifications:
Infectious Disease, 2000
Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Otago /Dunedin Medical School
Medical School
Cleveland Met Gen Hosp
Medical School
Stanford U Mc
Jeffery Loutit Photo 2

Jeffery Stuart Loutit

View page
Specialties:
Internal Medicine
Infectious Disease
Education:
University Of Otago (1981)

Public records

Vehicle Records

Jeffery Loutit

View page
Address:
1190 Brucito Ave, Los Altos, CA 94024
Phone:
(650) 888-5007
VIN:
JF1GPAK63CH236722
Make:
SUBARU
Model:
IMPREZA
Year:
2012

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jeffery Stuart Loutit
Jeffery Loutit MD
Internist
1190 Brucito Ave, Los Altos, CA 94024
(650) 725-3872

Publications

Us Patents

Altering Pharmacokinetics Of Pirfenidone Therapy

View page
US Patent:
20080287508, Nov 20, 2008
Filed:
Jan 25, 2008
Appl. No.:
12/020068
Inventors:
Cynthia Y. Robinson - Burlingame CA, US
Jeffery S. Loutit - Los Altos CA, US
Michelle M. Freemer - Mill Valley CA, US
Assignee:
INTERMUNE, INC. - Brisbane CA
International Classification:
A61K 31/44
US Classification:
514350
Abstract:
The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl--phenyl-2-(1H)-pyridone) therapy.

Altering Pharmacokinetics Of Pirfenidone Therapy

View page
US Patent:
20110136876, Jun 9, 2011
Filed:
Feb 16, 2011
Appl. No.:
13/028827
Inventors:
Cynthia Y. Robinson - Burlingame CA, US
Jeffery S. Loutit - Los Altos CA, US
Michelle M. Freemer - Mill Valley CA, US
Assignee:
INTERMUNE, INC. - Brisbane CA
International Classification:
A61K 31/4418
A61P 11/00
A61P 13/12
A61P 1/16
A61P 17/12
A61P 19/02
US Classification:
514345
Abstract:
The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.

Use Of Aerosolized Antibiotics For Treating Chronic Obstructive Pulmonary Disease

View page
US Patent:
20120237564, Sep 20, 2012
Filed:
Feb 16, 2012
Appl. No.:
13/398310
Inventors:
Michael N. Dudley - San Diego CA, US
Neil Berkley - San Diego CA, US
David C. Griffith - San Marcos CA, US
Jeffery S. Loutit - Los Altos CA, US
Elizabeth E. Morgan - Escondido CA, US
Keith A. Bostian - Atherton CA, US
Sanjay Sethi - East Amherst NY, US
Assignee:
MPEX Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/5383
A61K 9/14
A61P 11/08
A61K 31/56
A61P 11/00
A61P 31/04
US Classification:
424400, 5142302, 514171
Abstract:
The present invention relates to methods and compositions for treating obstructive pulmonary disorders. In particular, compositions and methods described herein relate to the use of an aerosolized antibiotic for treating obstructive pulmonary disorders including chronic obstructive pulmonary disorder (COPD) and chronic bronchitis (CB).

Use Of Aerosolized Levofloxacin For Treating Cystic Fibrosis

View page
US Patent:
20120276153, Nov 1, 2012
Filed:
Mar 5, 2012
Appl. No.:
13/412423
Inventors:
Jeffery S. Loutit - Los Altos CA, US
Elizabeth E. Morgan - Escondido CA, US
Michael N. Dudley - San Diego CA, US
David C. Griffith - San Marcos CA, US
Olga Lomovskaya - Mountain View CA, US
Assignee:
MPEX PHARMACEUTICALS, INC. - San Diego CA
International Classification:
A61K 31/5383
A61P 31/04
A61P 11/00
A61P 11/08
A61K 9/12
A61P 37/00
A61K 31/56
US Classification:
424400, 5142302, 514171
Abstract:
Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising

Altering Pharmacokinetics Of Pirfenidone Therapy

View page
US Patent:
20130225639, Aug 29, 2013
Filed:
Apr 5, 2013
Appl. No.:
13/857465
Inventors:
Jeffery S. Loutit - Los Altos CA, US
Michelle M. Freemer - Mill Valley CA, US
Assignee:
INTERMUNE, INC. - Brisbane CA
International Classification:
A61K 31/4418
US Classification:
514345
Abstract:
The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.

Methods Of Reducing Adverse Events Associated With Pirfenidone Therapy

View page
US Patent:
20070203202, Aug 30, 2007
Filed:
Nov 28, 2006
Appl. No.:
11/605199
Inventors:
Cynthia Robinson - Burlingame CA, US
Jeffery Loutit - Los Altos CA, US
Michelle Freemer - Mill Valley CA, US
International Classification:
A61K 31/4412
US Classification:
514345000
Abstract:
The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.

Altering Pharmacokinetics Of Pirfenidone Therapy

View page
US Patent:
20140221434, Aug 7, 2014
Filed:
Apr 7, 2014
Appl. No.:
14/246414
Inventors:
- Brisbane CA, US
Jeffery S. Loutit - Los Altos CA, US
Michelle M. Freemer - Mill Valley CA, US
Assignee:
INTERMUNE, INC. - Brisbane CA
International Classification:
A61K 31/4418
US Classification:
514345
Abstract:
The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.
Jeffery S Loutit from Los Altos, CA, age ~67 Get Report